Platelet

Olive Lifesciences.claims bioavailability of its curcuminoid formulation BioTurmin-WD is more potent than 95% pure curcuminoids

Curcumin bioavailability boosted 7x: Industry study

By Nicola Cottam

The bioavailability of micronutrients in a proprietary curcuminoid formulation is seven times more potent than 95% pure curcuminoids, say researchers from the Indian manufacturer Olive Lifesciences.

Provexis commits to CV and immunity research

Provexis commits to CV and immunity research

By Shane Starling

Biotech start-up Provexis says it will commence two clinical trials in 2011 – one in the area of cardiovascular inflammation, the other in treatment of “hospital superbug” c.difficile.

Provexis tomato extract claim approved by EC

Provexis tomato extract claim approved by EC

By Shane Starling

More than six months after receiving a positive health claim opinion from the European Food Safety Authority (EFSA) linking its tomato extract to blood circulation benefits, UK biotech firm Provexis has been handed final claim wording by the European...

Tomato extract wins EFSA blood aggregation health claim

EFSA health claim opinion

Tomato extract wins EFSA blood aggregation health claim

By Shane Starling

UK-based Provexis Natural Products Limited has won a positive article 13.5 claim linking tomato concentrate consumption and blood platelet aggregation from the European Food Safety Authority (EFSA).

Spotlight

Follow us

Featured Events

View more

Products

View more

Webinars

Featured Suppliers

All suppliers